---
title: "ADMA.US (ADMA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ADMA.US/news.md"
symbol: "ADMA.US"
name: "ADMA.US"
parent: "https://longbridge.com/en/quote/ADMA.US.md"
datetime: "2026-05-20T15:01:04.175Z"
locales:
  - [en](https://longbridge.com/en/quote/ADMA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADMA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADMA.US/news.md)
---

# ADMA.US (ADMA.US) — Related News

### [17:28 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA](https://longbridge.com/en/news/286821593.md)
*2026-05-18T21:28:58.000Z*
> Rosen Law Firm is investigating potential securities claims for ADMA Biologics, Inc. shareholders due to allegations of 

### [20:15 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA](https://longbridge.com/en/news/286483885.md)
*2026-05-15T00:17:20.000Z*
> Pomerantz Law Firm is investigating claims on behalf of investors of ADMA Biologics, Inc. regarding potential securities

### [A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations](https://longbridge.com/en/news/286183122.md)
*2026-05-13T02:11:24.000Z*
> ADMA Biologics (ADMA) faces scrutiny after short seller allegations of channel stuffing related to ASCENIV, leading to i

### [17:24 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA](https://longbridge.com/en/news/286160374.md)
*2026-05-12T21:25:38.000Z*
> Rosen Law Firm is investigating potential securities claims for shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) due 

### [03:18 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA](https://longbridge.com/en/news/285679653.md)
*2026-05-08T07:19:00.000Z*
> Rosen Law Firm is investigating potential securities claims for shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) due 

### [](https://longbridge.com/en/news/285572181.md)
*2026-05-07T14:33:18.000Z*
> The Nasdaq Biotechnology Index fell more than 1.9%. Among its constituents, Entrada Therapeutics dropped 55.80%, Phibro 

### [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://longbridge.com/en/news/285548857.md)
*2026-05-07T12:06:21.000Z*
> In Thursday's pre-market session, several health care stocks experienced significant movements. Agilon Health (AGL) surg

### [Adma Biologics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 114.49 M](https://longbridge.com/en/news/285476736.md)
*2026-05-07T03:08:59.000Z*
### [ADMA (ADMA) Q1 2026 Earnings Transcript](https://longbridge.com/en/news/285452089.md)
*2026-05-06T23:00:29.000Z*
> The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of

### [](https://longbridge.com/en/news/285437997.md)
*2026-05-06T20:51:53.000Z*
> ADMA Biologics shares are trading lower after the company reported worse-than-expected Q1 financial results and issued F